Gene · 5981
Papers2,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,391
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Multifactorial Causes of Down Syndrome During Pregnancy: A Narrative Review of Genetic, Environmental, and Maternal Influences. | Health Sci Rep | 2025 | 41356612 | PubTator, text mining | PubMed |
| ITPR1 Deletion in a Patient With Sensory Ataxic Neuropathy and Sjögren Syndrome. | J Peripher Nerv Syst | 2025 | 41325768 | PubTator, text mining | PubMed |
| Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with RFC1 expansions. | Brain Commun | 2025 | 41322202 | PubTator, text mining | PubMed |
| RPA1, RFC1, and POLE Expression in Clear Cell Renal Cell Carcinoma: Immune and Clinical Relevance. | Anticancer Res | 2025 | 41318151 | PubTator, text mining | PubMed |
| Long-read sequencing reveals extensive FMR1 somatic mosaicism in Fragile-X associated tremor/ataxia syndrome in human brain. | bioRxiv | 2025 | 41278766 | PubTator, text mining | PubMed |
| Nerve ultrasound abnormality in RFC1 positive isolated sensory neuropathy is milder than in the full RFC1 canvas phenotype. | Clin Neurophysiol Pract | 2025 | 41209352 | PubTator, text mining | PubMed |
| RFC4 Drives Pancreatic Cancer Progression: Prognostic Relevance and Functional Evidence. | Anticancer Res | 2025 | 41151897 | PubTator, text mining | PubMed |
| Comprehensive phenotyping of RFC1-related disorder: integrating electrophysiological, brain imaging, and otoneurological data in deep phenotyping. | Arq Neuropsiquiatr | 2025 | 41145152 | PubTator, text mining | PubMed |
| Mitochondria-enriched nanovesicles: A novel approach for treating radiation-induced skin injury. | Mater Today Bio | 2025 | 41142427 | PubTator, text mining | PubMed |
| First Report of Co-Occurring FGF14 (SCA27B) and RFC1 (CANVAS) Repeat Expansions in Two of Three Siblings with Late-Onset Cerebellar Ataxia. | Cerebellum | 2025 | 41118032 | PubTator, text mining | PubMed |
| Pseudodominant Inheritance of Biallelic RFC1 Expansions-Revisiting the 3p22-p24 HSN1B Locus. | J Peripher Nerv Syst | 2025 | 41084404 | PubTator, text mining | PubMed |
| Video head impulse test differentiates RFC1-CANVAS, FGF14-SCA27B, and idiopathic late-onset cerebellar ataxias. | J Neurol | 2025 | 41055766 | PubTator, text mining | PubMed |
| Advances in Modeling the Inner Blood-Retinal Barrier: From Static Tissue Cell Cultures to Microphysiological Systems. | Pharmaceuticals (Basel) | 2025 | 41011242 | PubTator, text mining | PubMed |
| Progress and challenges in sporadic late-onset cerebellar ataxias. | Nat Rev Neurol | 2025 | 40983776 | PubTator, text mining | PubMed |
| Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. | Discov Oncol | 2025 | 40947455 | PubTator, text mining | PubMed |
| DNA polymerase α-primase can function as a translesion DNA polymerase. | Proc Natl Acad Sci U S A | 2025 | 40928879 | PubTator, text mining | PubMed |
| Longitudinal Evaluation of Ataxia and Brain Structural Changes in RFC1-Related Disorder. | Mov Disord Clin Pract | 2025 | 40908706 | PubTator, text mining | PubMed |
Diagnostic Impasse and Wandering in Patients With Rare Neuromuscular Diseases: Insights Into Patient Characteristics From the French National Network for Rare Neuromuscular Diseases (FILNEMUS) and the French National Rare Disease Database (BNDMR). | Eur J Neurol | 2025 | 40905397 | PubTator, text mining | PubMed |
| Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease. | medRxiv | 2025 | 40894141 | PubTator, text mining | PubMed |
| Prevalence and Clinical Correlates of Sleep Disorders in RFC1-Spectrum Disorders: A Cross-Sectional Study. | Mov Disord | 2025 | 40879541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5981/papers?page=4